Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Colorectal Cancer (mCRC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT02205398
What this trial is testing

Study of Safety and Efficacy of INC280 and Cetuximab, in Adult c-MET Positive mCRC and HNSCC Patients After Progression on Cetuximab or Panitumumab Therapy

Who this might be right for
Squamous Cell Carcinoma of Head and Neck (SCCHN)Metastatic Colorectal Cancer
Novartis Pharmaceuticals 13
Testing effectiveness (Phase 2)Looking for participantsNCT05286814
What this trial is testing

PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma

Who this might be right for
Metastatic Colorectal Cancer (Mcrc)Intrahepatic Cholangiocarcinoma (Icc)Intrahepatic Bile Duct Cancer+10 more
National Cancer Institute (NCI) 70
Large-scale testing (Phase 3)UnknownNCT02942706
What this trial is testing

Cetuximab Maintenance Treatment Versus Continuation After Induction Therapy in mCRC

Who this might be right for
Colorectal Cancer
Ruijin Hospital 200
Testing effectiveness (Phase 2)WithdrawnNCT03222089
What this trial is testing

Phase II Trial of FOLFOXIGIL Versus FOLFOXIRI as First-line Therapy in Patients With mCRC

Who this might be right for
Metastatic Colorectal Cancer
Fujian Cancer Hospital
Not applicableUnknownNCT06099314
What this trial is testing

Fruquintinib in the Cross-line Treatment of Refractory mCRC

Who this might be right for
FruquintinibMetastatic Colorectal Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 36
Testing effectiveness (Phase 2)Study completedNCT00332163
What this trial is testing

Skin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based Therapy

Who this might be right for
Metastatic Colorectal CancerSkin RashSkin Toxicities+2 more
Amgen 95
Early research (Phase 1)Ended earlyNCT04108481
What this trial is testing

Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer MetastaticColon CancerMetastatic Colorectal Cancer+7 more
University of Iowa 5
Testing effectiveness (Phase 2)Ended earlyNCT03563157
What this trial is testing

QUILT 3.071: NANT Colorectal Cancer (CRC) Vaccine

Who this might be right for
Colorectal Cancer MetastaticmCRC
ImmunityBio, Inc. 2
Large-scale testing (Phase 3)Not Yet RecruitingNCT07134205
What this trial is testing

The Study of JMT101 Combined With Irinotecan as a ≥3rd-Line Treatment in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer (mCRC)
Shanghai JMT-Bio Inc. 252
Testing effectiveness (Phase 2)Looking for participantsNCT04701476
What this trial is testing

TATE and Pembrolizumab (MK3475) in mCRC and NSCLC

Who this might be right for
Colorectal Cancer; Lung Cancer
Teclison Ltd. 110
Testing effectiveness (Phase 2)UnknownNCT04097444
What this trial is testing

CAPOXIRI+Bevacizumab vs. FOLFOXIRI+Bevacizumab for mCRC

Who this might be right for
Metastatic Colorectal Cancer
Chugai Pharmaceutical 112
Not applicableNo Longer AvailableNCT06195514
What this trial is testing

Expanded Access to TAK-113 for Adults With Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Colorectal Cancer
Takeda
Not applicableStudy completedNCT01039506
What this trial is testing

An Observational Study of CPT-11 Based Regimens and UGT1A1 Genotypes in Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Metastatic Colorectal Cancer
Daiichi Sankyo Co., Ltd. 1,376
Testing effectiveness (Phase 2)Looking for participantsNCT06922383
What this trial is testing

A Clinical Study of Arfolitixorin in Patients With mCRC

Who this might be right for
Metastatic Colorectal Cancer (mCRC)
Isofol Medical AB 90
Large-scale testing (Phase 3)Study completedNCT01183780
What this trial is testing

A Study in Second Line Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Eli Lilly and Company 1,072
Early research (Phase 1)UnknownNCT02211443
What this trial is testing

Safety, Tolerability and Pharmacokinetics of Recombinant Anti-epidermal Growth Factor Receptor(EGFR) Monoclonal Antibody in Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Sinocelltech Ltd. 21
Not applicableStudy completedNCT04926376
What this trial is testing

Safety and Effectiveness of Eye90 Microspheres™ in the Treatment of Unresectable Hepatocellular Carcinoma (HCC) and Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Hepatocellular Carcinoma Non-resectableMetastatic Colorectal CancerLiver Cancer
ABK Biomedical 8
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07150403
What this trial is testing

Second-line Doublet Chemotherapy (FOLFOX or FOLFIRI) Plus Fruquintinib Versus Doublet Chemotherapy (FOLFOX or FOLFIRI) Plus Bevacizumab in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Carcinoma (mCRC)
Federation Francophone de Cancerologie Digestive 74
Testing effectiveness (Phase 2)UnknownNCT05229003
What this trial is testing

Irinotecan Plus Anlotinib or Further in Combination With Penpulimab for Second-line Treatment of mCRC

Who this might be right for
Metastatic Colorectal Cancer
Fudan University 44
Large-scale testing (Phase 3)WithdrawnNCT01786538
What this trial is testing

Second-line FOLFOX With or Without Regorafenib in mCRC Patients Failed to First-line Irinotecan Plus Fluoropyrimidines

Who this might be right for
Metastatic Colorectal Cancer
Asan Medical Center
Next Page